Full name
IZERSKIE CENTRUM PULMONOLOGII I CHEMIOTERAPII "IZER-MED" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.10.Z - Hospital activities
68 - Real estate activities
86 - Healthcare
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | 3 | 3,9 | 28,8 |
EBITDA | 4 | 5 | 25,1 |
Short time liabilities | 3,7 | 3 | -19,5 |
Equity capital | 14,4 | 17,4 | 20,7 |
Operating profit (EBIT) | 2,9 | 3,6 | 26,3 |
Assets | 19,8 | 23,3 | 17,3 |
Net profit (loss) | 2,4 | 3,2 | 29,6 |
Cash | 9,9 | 11,2 | 12,6 |
Net income from sale | 31,1 | 35,4 | 13,7 |
Liabilities and provisions for liabilities | 5,5 | 5,9 | 8,2 |
Working assets | 15,3 | 16,2 | 5,8 |
Depreciation | 1,1 | 1,3 | 21,7 |
% | % | p.p. | |
Profitability of capital | 16,9 | 18,2 | 1,3 |
Equity capital to total assets | 72,5 | 74,7 | 2,2 |
Gross profit margin | 9,7 | 11 | 1,3 |
EBITDA Margin | 12,8 | 14 | 1,2 |
Days | Days | Days | |
Short term commitment turnover cycle | 43 | 31 | -12 |
Current financial liquidity indicator | 2.800877332687378 | 2.739083766937256 | -0,1 |
Net dept to EBITDA | -2.494891881942749 | -2.2468550205230713 | 0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane